New Diet Drug in Battle of the Bulge

January 11, 2008 | Source: Scientific American

Merck researchers report that the cannabinoid receptor blocking drug taranabant helped obese patients lose weight during a 12-week trial, even at low doses ranging from 0.5 to six milligrams.

Taranabant is the second appetite suppressant and weight-loss drug that works by blocking cannabinoid receptors.